drug
as of 2026-07-01JNJ-40411813
at a glance
small molecule
Pre-approval / investigational in the US
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With Schizophrenia
NCT01323205Phase 2Completed
Ketamine Challenge Study With JNJ-40411813
NCT01101659Phase 1Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication